Wegovy is not universally classified as a specialty drug, though some insurance plans and pharmacy benefit managers do place it on a specialty tier. Whether you encounter specialty drug requirements depends entirely on your specific insurer and plan design. On the 2025 OptumRx Specialty Drug List, for example, Wegovy does not appear at all, meaning it’s treated as a standard medication under those plans.
What Makes a Drug “Specialty”
The specialty drug label comes from a set of criteria that pharmacy benefit managers and insurers use to categorize high-cost or complex medications. The most concrete threshold comes from Medicare Part D, where CMS defines specialty tier eligibility as drugs with negotiated prices exceeding $600 per month. That threshold has been in place since 2008, and fewer than 1% of all prescription claims exceed it.
Beyond cost, specialty drugs typically share other traits: they need special storage or handling, require close clinical monitoring, treat complex conditions, or are used by only a small percentage of patients. Wegovy checks some of these boxes but not others, which is why its classification varies across plans.
Why Wegovy Sits in a Gray Area
Wegovy’s list price comfortably exceeds the $600 monthly threshold that triggers specialty tier consideration under Medicare. That cost alone is enough for some insurers to slot it into their specialty category, which typically means higher copays or coinsurance for you.
The injectable form of Wegovy also has cold-chain requirements that lean toward specialty handling. The pens need refrigeration between 36°F and 46°F, and while they can be kept at room temperature for up to 28 days if the cap stays on, exposure to extreme heat or cold can damage the medication. These storage demands mean the drug needs careful shipping, which specialty pharmacies are built to handle.
On the other hand, Wegovy doesn’t require infusion at a clinic, doesn’t need a healthcare provider to administer it, and is now widely available through standard retail channels. The newer oral formulation of Wegovy is distributed through retail pharmacies, including Amazon Pharmacy, which makes it look much more like a conventional prescription than a specialty product. This mix of specialty-like cost with retail-like accessibility is exactly why plans disagree on how to categorize it.
How Classification Affects Your Experience
If your plan treats Wegovy as a specialty drug, you’ll notice a few practical differences. You may be required to fill it through a designated specialty pharmacy or mail-order service rather than picking it up at your local drugstore. Specialty tiers also carry higher cost-sharing, often structured as coinsurance (a percentage of the drug’s price) rather than a flat copay, which can mean significantly larger out-of-pocket costs each month.
Plans that classify Wegovy on a non-specialty tier, sometimes called a preferred or non-preferred brand tier, generally allow you to fill it at retail pharmacies and charge a more predictable copay. Some plans also offer 90-day fills through mail order at a lower coinsurance rate, which can be combined with Novo Nordisk’s savings program to reduce costs further. That savings program can bring your cost as low as $0 with eligible commercial insurance, though the specific discount depends on your plan details and the pharmacy you use.
Prior Authorization Is Common Either Way
Regardless of whether your plan labels Wegovy as specialty, most insurers require prior authorization before they’ll cover it. The specific criteria vary, but they typically involve documented BMI thresholds and sometimes additional medical conditions. Maryland Medicaid, for instance, requires documented cardiovascular disease along with a BMI of at least 27, confirmed within the last 90 days, and also excludes patients with type 1 or type 2 diabetes (who would use a different semaglutide product).
Private insurers set their own rules, but most require your prescriber to submit clinical documentation showing you meet their coverage criteria. This process can take anywhere from a few days to a couple of weeks. If your plan does route Wegovy through a specialty pharmacy, the pharmacy’s staff often helps coordinate the prior authorization, which can actually streamline the process compared to handling it through a retail pharmacy.
How to Find Out Your Plan’s Classification
The fastest way to check is to look up your plan’s formulary, which is the list of covered drugs organized by tier. Most insurers publish this on their website or member portal. Search for semaglutide or Wegovy and note which tier it falls on. If it’s listed on a “specialty” tier, that’s your answer for your specific coverage.
You can also call the number on the back of your insurance card and ask two direct questions: whether Wegovy is on a specialty tier, and whether you’re required to use a specific pharmacy to fill it. Those two answers will tell you what your real out-of-pocket cost and pickup process will look like. If you’re paying cash without insurance, the specialty distinction is irrelevant since you can purchase it at any pharmacy that stocks it.